ArticleRadiation protection dosimetry2026
Improving visibility of small anatomical details on low and ultra-low dose computed tomography with artificial intelligence-based image reconstructions.
Article in Radiation protection dosimetry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
To assess how computed tomography (CT) image reconstruction techniques affect perceived diagnostic image quality at varying radiation dose levels in chest imaging. A PBU-50 anthropomorphic phantom (small adult-sized model) and an air-dried human lung specimen were scanned on the same CT system (Revolution Apex™, GE Healthcare) at six dose levels (CTDIvol) from 0.07 to 2.19 mGy for the smallest phantom size. Images were reconstructed using deep learning image reconstruction-high (DLIR-H), adaptive statistical iterative reconstruction at 40 per cent (ASiR-V), and filtered back projection (FBP). Five radiologists assessed anatomical reproduction, noise, artefacts, and diagnostic quality using ViewDEX. Descriptive statistics and visual grading characteristics analysis were used. In general, DLIR-H scored higher than ASiR-V and FBP. While maintaining image quality, DLIR-H allowed dose reduction compared to FBP. All methods were deemed acceptable for diagnosing pulmonary nodules, fibrosis, and peribronchial pathology. The results indicate that DLIR-H improves image quality in comparison to FBP and ASiR-V and may enable radiation dose reduction while maintaining clinical image quality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.